US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Murray Cod Australia Limited (MCA) 銘柄情報

Murray Cod Australia Limited (MCA)

0.145

0.005

(3.57%)

終了 6月13日 3:00PM

Murray Cod Australia Limited (MCA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.145

( 3.57% )

買値

0.145

売値

0.155

出来高

293,875

0.14 日の範囲 0.145

0.135 52 週間の範囲 1.185

時価総額

前日終値

0.14

始値

0.14

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 476,174

発行済株式数

116,076,628

配当利回り

PER

5.69

1 株当たり利益 (EPS)

-

歳入

12.78M

純利益

3.16M

Murray Cod Australia Limited, together with its subsidiaries, breeds, grows, and markets freshwater and table fish in Australia. The company breeds and sells Murray cod, Golden perch, and Silver perch as fingerlings. It also provides aquaculture equipment; and sells cattle. The company exports its p... Murray Cod Australia Limited, together with its subsidiaries, breeds, grows, and markets freshwater and table fish in Australia. The company breeds and sells Murray cod, Golden perch, and Silver perch as fingerlings. It also provides aquaculture equipment; and sells cattle. The company exports its products in Southeast Asia, including Indonesia, Hong Kong, Maldives, Singapore, Thailand, and Vietnam. Murray Cod Australia Limited is headquartered in Griffith, Australia. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Foods

ウェブサイト

aquna.com

本社

Griffith, Australia

設立

-

Murray Cod Australia Limited is listed in the Consumer Staples sector of the オーストラリア証券取引所 with ticker MCA. The last closing price for Murray Cod Australia was AUD0.14. Over the last year, Murray Cod Australia shares have traded in a share price range of AUD 0.135 to AUD 1.185.

Murray Cod Australia currently has 116,076,628 shares in issue. The market capitalisation of Murray Cod Australia is AUD16.83 million. Murray Cod Australia has a price to earnings ratio (PE ratio) of 5.69.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-12.1212121212	0.165	0.165	0.14	279633	0.14877321	DE
4	-0.02	-12.1212121212	0.165	0.185	0.14	290543	0.1614548	DE
12	-0.265	-64.6341463415	0.41	0.51	0.135	353772	0.1993418	DE
26	-0.885	-85.9223300971	1.03	1.08	0.135	218425	0.32297771	DE
52	-0.78	-84.3243243243	0.925	1.185	0.135	125726	0.43856267	DE
156	0.015	11.5384615385	0.13	1.43	0.07	277668	0.17981048	DE
260	-0.24	-62.3376623377	0.385	1.43	0.07	252918	0.19493693	DE

MCA - Frequently Asked Questions (FAQ)

What is the current Murray Cod Australia Limited share price?

The current share price of Murray Cod Australia Limited is AUD 0.145

How many Murray Cod Australia Limited shares are in issue?

Murray Cod Australia Limited has 116,076,628 shares in issue

What is the market cap of Murray Cod Australia Limited?

The market capitalisation of Murray Cod Australia Limited is AUD 16.83M

What is the 1 year trading range for Murray Cod Australia Limited share price?

Murray Cod Australia Limited has traded in the range of AUD 0.135 to AUD 1.185 during the past year

What is the PE ratio of Murray Cod Australia Limited?

The price to earnings ratio of Murray Cod Australia Limited is 5.69

What is the cash to sales ratio of Murray Cod Australia Limited?

The cash to sales ratio of Murray Cod Australia Limited is 2.32

What is the registered address of Murray Cod Australia Limited?

The registered address for Murray Cod Australia Limited is 2-4 Lasscock Road, Griffith, New South Wales, 2680

What is the Murray Cod Australia Limited website address?

The website address for Murray Cod Australia Limited is aquna.com

Which industry sector does Murray Cod Australia Limited operate in?

Murray Cod Australia Limited operates in the Consumer Products - Foods sector

Split T

Split T 3分前

Musk has literally guaranteed this employees a verybhansome and maximum return with no chance of the stock catering before they all dispose of what they wish to sell. SMART MOVE FOR HIM AND HIS EMPLOYEE'S . iMo they will be able to buy back in when it tanks for the first time. IT is not worth the

81vette

81vette 17分前

I understand now,merger was complete but had a 20 day mandatory conversion waiting period from filing date ,it ended Wednesday and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good with insti

RockQQ

RockQQ 18分前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 20分前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 21分前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 30分前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 31分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 35分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 36分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 38分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 42分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 45分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 52分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 53分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 53分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 54分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 55分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 57分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 57分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 1時間前

Just give me $1.50

Just give me $1.50 1時間前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 1時間前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

Murray Cod Australia

MustGrow Biologics

1.8% until 5sep2026

Schroder UK Mid Cap

KraneShares ICAV

Augur Reputation v2

Sun Summit Minerals

Peninsula Energy

Fintech Scion (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。